海外の治験の状況「COVID-19」での検索結果
210件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Cancer Molecular Screening and Therapeutics (MoST) Program Substudy Addendum 8 substudy 19: T-DM1
- Cancer; Cancer;Cancer - Any cancer
- Australia
- 2019-09-12
Not recruiting
- CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
- Non Hodgkin Lymphoma (NHL);Mantle Cell Lymphoma (MCL)
- 2019-12-02
Not Recruiting
- Intervention trial to study the effect of iron enriched Spirulina incorporated food items among non pregnant anemic women of 19 to 30 years.
- Mild Iron Deficiency Anemia ( 11gms% to less than 12gms%)
- India
- 2019-12-03
Not Recruiting
- Pexacerfont (A Selective Non-Peptide CRF1 Antagonist) and Treatment of substance withdrawal.
- Substance dependency. Mental and behavioural disorders due to psychoactive substance use;F10-19;Mental and behavioural disorders due to psychoactive substance use
- Iran (Islamic Republic of)
- 2015-03-03
Not Recruiting
- Bioequivalence of Single Dose Zydus pegfilgrastim to Neulasta® pegfilgrastim from US and EU Sources
- Age 18-45 years, BMI 19 to 25kg/m2
- India
- 2013-04-23
Not recruiting
- Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer
- Breast Neoplasms;mTor Protein
- France
- 2011-02-16
Not Recruiting
- The efficacy and safety of rituximab in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody
- Neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody
- Japan
- 2015-10-09
Not Recruiting
- Study for preventive effect and mechanism of gonadotropin-releasing hormone antagonist and aromatase inhibition on early-onset ovarian hyperstimulation syndrome after oocyte extraction
- ovarian hyperstimulation syndrome
- China
- 2019-02-12
Not Recruiting
- Effect of Subcutaneous Needling on VAS, IgG and IgM in patients with lumbar disc herniation
- Lumbar disc herniation
- China
- 2019-06-23
Not recruiting
- Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
- Epilepsy
- United States
- 2014-05-14